View the content of this email online

Efficient and safe delivery of multiple mRNA using LentiFlash® for cell therapy and vaccination.

Newsletter LF
LentiFlash® technology leads to multiple coding and non-coding RNA species delivery in vitro & in vivo.

LentiFlash® technology allows the delivery of multiple sequences of interest for different applications such as :


Vaccination against one or several antigens

Gene-editing in vitro and in vivo

Regenerative medicine

(data from ESGCT meeting 2021)

ESGCT 2021

Find out more

Click Here

Follow us

Twitter Flash Therapeutics LinkedIn Flash Therapeutics Youtube Flash Therapeutics
© Flash Therapeutics 2018

Click here to unsuscribe from the mailing list